HomeClinical TopicsFDA updates Tasigna label to include stop treatment options

FDA updates Tasigna label to include stop treatment options

Author(s):

On Dec. 22, the U.S. Food and Drug Administration (FDA) updated the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response.

Read more via Fda.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...